monoclonal


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

mon·o·clo·nal

 (mŏn′ə-klō′nəl)
adj.
Derived as clones from a single cell or produced by clones of a single cell: a monoclonal tumor.
n.
A monoclonal product, such as a monoclonal antibody.

monoclonal

(ˌmɒnəʊˈkləʊnəl)
adj
(Biology) biology relating to or produced from a single cell or clone

mon•o•clo•nal

(ˌmɒn əˈkloʊn l)
adj.
1. pertaining to cells or cell products derived from a single biological clone.
n.
2. a monoclonal antibody or other monoclonal product.
[1910–15]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.monoclonal - any of a class of antibodies produced in the laboratory by a single clone of cells or a cell line and consisting of identical antibody molecules
antibody - any of a large variety of proteins normally present in the body or produced in response to an antigen which it neutralizes, thus producing an immune response
infliximab, Remicade - a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
Adj.1.monoclonal - forming or derived from a single clone
Translations

mon·o·clo·nal

a. monoclonal, rel. a un solo grupo de células;
___ antibodiesanticuerpos ___ -es.

monoclonal

adj monoclonal
References in periodicals archive ?
monoclonal antibody against human cd11b labeled with pe 100 units, 1,000 byn2.
The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the monoclonal antibody therapeutics market in the current and future scenario.This report analyzes the current and future prospects of the monoclonal antibody therapeutics market based on type of application, source, end user and geography.
[ClickPress, Thu Apr 18 2019] Looking at the current market trends as well as the promising demand status of the " Monoclonal Antibody Therapeutics Market ", it can be projected that the future years will bring out positive outcomes.
AC Immune announced that Genentech is recruiting patients for a second Phase 2 trial for an anti-Tau monoclonal antibody, known as MTAU9937A, RO7105705, in moderate Alzheimer's disease, or AD.
[USPRwire, Fri Dec 28 2018] A new report titled " Global Monoclonal Antibody Therapeutics Market Investigation and Growth Forecasted Until the End of 2024 " has been included in the enormous research repository of Market Research Reports Search Engine (MRRSE) that compiles various facets of the Monoclonal Antibody Therapeutics Market at a global level portraying a holistic analysis of the marketplace along with intelligence on key participants.
M2 EQUITYBITES-December 5, 2018-Innovent to launch clinical trials of Anti-OX40 Monoclonal Antibody IBI101 upon US FDA approval
Global Banking News-December 5, 2018-Innovent to launch clinical trials of Anti-OX40 Monoclonal Antibody IBI101 upon US FDA approval
M2 PHARMA-December 5, 2018-Innovent to launch clinical trials of Anti-OX40 Monoclonal Antibody IBI101 upon US FDA approval
THURSDAY, May 10, 2018 (HealthDay News) -- Patients receiving immunotherapy with antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies may develop uveal effusion, according to a report published online April 12 in JAMA Ophthalmology.
Background and Objectives: Monoclonal gammopathy of undetermined significance (MGUS) is the most prevalent among the group of disorders called Plasma cell dyscrasias.
Although AL amyloidosis and monoclonal immunoglobulin deposition disease (light-chain deposition disease and heavy-chain deposition disease, resp.) are both characterized by monoclonal immunoglobulin deposits in tissues, these diseases are distinguishable strictly by Congo red staining and characteristic appearance on electron microscopy.
San Jose, CA, November 24, 2016 --(PR.com)-- Credence Research has recently issued a new market assessment report titled "Therapeutic Monoclonal Antibodies - Growth, Future Prospects and Competitive Analysis, 2016 - 2022." The global Therapeutic Monoclonal Antibodies Market study provides a comprehensive view of the ongoing and future phases of the Therapeutic Monoclonal Antibodies industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution.